Single cell analysis with 12 groups Those patient without lymphocytic infiltrates were different! Mitochondria were the differentiator in these patients. Fibroblasts and CD8+ T cells are the most actively communicating cells. - Chemokines and ECM https://t.co/Pe0WSoYdXT

Tenosynovitis, bone marrow lesions and synovitis quantification in #RA #MRI Labelled data and training sets are the key! #EULAR2024 @rheumnow abst#0190 https://t.co/irDaFrxBH5

Deep learning software to evaluate CTD-ILD abst#0167 Lots of computer vision/ imaging performance studies at #EULAR2024 Using segmentation to evaluate lung abnormalities @rheumnow https://t.co/9aXIymAM6X

🗣️Lowering glucocorticoids dose remains a key goal in #lupus management Prof @EricFMorand at #EULAR2024 #letpushbelow5 mg of prednisone in #SLE https://t.co/IeiLh2zVrT

End stage Knee Oa predictive tool 2 to 5 years now available online. using MOST and OAI open access data #EULAR2024 abst#0203 @RheumNow Can help in more efficient Knee OA clinical trials. https://t.co/AhhoczsuHU

#EULAR2024 Reminder … 🔺Anti-drug antibodies cause significant variability in Therapeutic drug levels 🔺10% have undetectable drug level after 3 months of Rx 🔺is therapeutic drug monitoring is beneficial? 🤔 https://t.co/ChgMnKPyFb

Cardiovascular risk prediction in #RA using #AI chest xray imaging improves accuracy abst#0146 @RheumNow #EULAR2024 https://t.co/wtF5Sel8Tx

steroid dose 120 mg , repeated if not in remission 12 wks on background MTX - no difference between groups @rheumnow #EULAR2024 https://t.co/gkqmElfOCp

Deep learning to predict if an #RA patient will benefit from treatment using MRIs abst#0182 Models are still not good for mainstream practice- but will be in the future! Lots of fine tuning required #EULAR2024 #EULARBest @rheumnow https://t.co/9yVN6CHLCv

dual IL 17 A & F nanobody typical response at 12 wks not significantly better - how many IL17 inhibs do we need? ⁦@RheumNow⁩ #EULAR2024 https://t.co/50dIKyO0e4

Was a full room #EULAR2024 for the SELECT-GCA presentation (upadacitinib in GCA positive study). Palpable excitement through the audience here in Vienna @RheumNow https://t.co/bFL6mqqFAa